Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,906 shares at $455.06 ($872K) on 2025-02-18, disclosed to the SEC on 2025-02-19.
Scheduled sale ($872k) by SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $463.46 | 564 | $261K | 30.0% |
| 2 | $455.06 | 671 | $305K | 35.0% |
| 3 | $455.06 | 671 | $305K | 35.0% |
| Total | $457.55 avg | 1,906 | $872K | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |